POM

POMDOCTOR LIMITED American Depositary Shares

NASDAQ: POM · HEALTHCARE · PHARMACEUTICAL RETAILERS

$0.15

-1.18% today

Updated 2026-06-04

Market cap

$14.51M

P/E ratio

—

P/S ratio

0.04x

EPS (TTM)

$-0.33

Dividend yield

—

52W range

$0 – $6

Volume

8.5M

Market cap

$14.51M

P/E ratio

—

P/S ratio

0.04x

EPS (TTM)

$-0.33

Dividend yield

—

52W range

$0 – $6

Volume

8.5M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

6.7

Growth

4.5

Quality

2.5

Profitability

5.0

Valuation

C+

4/9

Piotroski F-Score

Moderate

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

—

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

Stock snapshot

Strengths

+ Revenue growth 17.20% QoQ

Risks

- Thin margins at -53.20%

- Negative free cash flow $-149.49M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$245.22M	$304.85M	$342.56M	$399.91M	$399.92M
Net income	$-125.51M	$-145.39M	$-143.36M	$-212.58M	$-212.58M
EPS	—	—	—	—	$-0.33
Free cash flow	$-22.02M	$-45.91M	$-16.17M	$-149.49M	$-149.49M
Profit margin	-51.18%	-47.69%	-41.85%	-53.16%	-53.20%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
POM	$14.51M	28	6.7	2.5	5.0	4.5	—	Avoid
LLY	$948.95B	78	10.0	10.0	5.0	6.0	—	Strong Buy
JNJ	$536.54B	59	4.7	9.0	3.3	6.0	-71.41%	Buy
ABBV	$380.57B	63	4.0	8.0	4.0	5.0	-55.64%	Buy
UNH	$343.21B	54	5.3	5.5	4.7	5.5	-26.61%	Buy
MRK	$285.64B	50	3.3	8.0	2.7	5.0	-49.34%	Hold

Smart narrative

POMDOCTOR LIMITED American Depositary Shares trades at $0.15. Our Smart Value Score of 28/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. TTM revenue stands at $399.92M. with profit margins at -53.20%.

Frequently asked questions

What is POMDOCTOR LIMITED American Depositary Shares's stock price?

POMDOCTOR LIMITED American Depositary Shares (POM) trades at $0.15, on a P/S of 0.0x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.

Is POMDOCTOR LIMITED American Depositary Shares overvalued?

POMDOCTOR LIMITED American Depositary Shares carries a Smart Value Score of 28/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is POMDOCTOR LIMITED American Depositary Shares's revenue?

POMDOCTOR LIMITED American Depositary Shares's trailing twelve-month revenue is $399.92M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.

Company info

SectorHEALTHCARE

IndustryPHARMACEUTICAL RETAILERS

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.7lk.com

Quick metrics

P/S ratio0.04x

ROE—

Beta—

50D MA$0.25

200D MA$1.46

Shares out0.12B

Float0.05B

Short ratio—

Avg volume8.5M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

POM vs LLY →POM vs JNJ →POM vs ABBV →Stock screener →